Vertex Pharmaceuticals Inc. buy Citigroup Inc.
Start price
14.11.24
/
50%
€470.80
Target price
14.11.25
€545.96
Performance (%)
-19.77%
Price
17:03
€377.70
This prediction will end soon
Summary
This prediction is currently active. The prediction for Vertex Pharmaceuticals Inc. disappoints with a performance of -19.77%. This prediction currently runs until 14.11.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 3.619% | 3.619% | -20.228% |
| iShares Core DAX® | 1.343% | -1.493% | 26.063% |
| iShares Nasdaq 100 | -1.235% | 0.457% | 8.184% |
| iShares Nikkei 225® | -2.386% | 4.669% | 17.678% |
| iShares S&P 500 | -0.486% | 0.800% | 3.258% |
Comments by Citigroup_Inc_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $575.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€346.50
02.10.25
02.10.25
€489.84
02.10.26
02.10.26
9.00%
17:03
17:03
